Inverse relationship between TCTP/RhoA and p53 /cyclin A/actin expression in ovarian cancer cells

Malgorzata Kloc1, Neelam Tejpal, Jitinderpal Sidhu

  • 1Department of Surgery, The Methodist Hospital, Houston, TX 77030, USA.

Insights

Translationally controlled tumor protein (TCTP) and RhoA inversely correlate with actin, p53, and cyclin A in ovarian cancer cells. This interaction may drive aggressive ovarian cancer progression.

Area of Science:

  • Oncology
  • Cell Biology
  • Biochemistry

Background:

  • The translationally controlled tumor protein (TCTP) influences cell growth, cell cycle, and cancer progression.
  • TCTP negatively affects p53 stability and interacts with the cytoskeleton, while cytoskeleton deregulation correlates with tumor cell migration and poor patient outcomes.
  • Cyclin A regulates the cell cycle, controls actin organization, and impacts cell motility via RhoA.

Purpose of the Study:

  • To investigate the organization of actin and cytokeratin cytoskeleton.
  • To examine the expression of TCTP, p53, cyclin A, RhoA, and actin.
  • To compare these factors in non-transformed ovarian epithelial cells and ovarian cancer cell lines with varying metastatic potential.

Main Methods:

  • Immunostaining
  • Ultrastructural analyses
  • Expression analysis of key proteins (TCTP, p53, cyclin A, RhoA, actin)

Main Results:

  • Significant differences in actin and cytokeratin organization were observed between non-transformed and cancer cells.
  • An inverse relationship was identified between TCTP/RhoA levels and actin/p53/cyclin A expression in ovarian cancer cell lines.
  • These findings highlight distinct cytoskeletal and molecular profiles in ovarian cancer.

Conclusions:

  • The study reveals a novel inverse relationship between TCTP/RhoA and actin/p53/cyclin A in ovarian cancer.
  • This interaction may be a critical factor contributing to the high aggressiveness of ovarian cancers.
  • Understanding these molecular dynamics could offer new therapeutic targets for ovarian cancer.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...